Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
42.25 Up 1.01(2.45%) Aug 28, 4:00PM EDT
|After Hours : 41.24 Down 1.01 (2.39%) Aug 28, 4:28PM EDT
Add to Portfolio
Prev Close:41.24
Open:40.97
Bid:36.00 x 1000
Ask:44.00 x 100
1y Target Est:47.55
Beta:2.24748
Earnings Date:Oct 28 - Nov 2 (Est.)
Day's Range:40.97 - 42.25
52wk Range:30.05 - 52.33
Volume:537,047
Avg Vol (3m):863,423
Market Cap:5.30B
P/E (ttm):N/A
EPS (ttm):-0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SGENUp 2.45%5.30B
IMGN 0.00%1.24B
PFEDown 1.80%201.43B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.96
Quarterly EPS Est (Sep-15) :-0.20
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-2.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback